Nations Financial Group Inc. IA ADV cut its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 1.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 8,230 shares of the conglomerate’s stock after selling 149 shares during the period. Nations Financial Group Inc. IA ADV’s holdings in Danaher were worth $2,288,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the business. CarsonAllaria Wealth Management Ltd. bought a new stake in Danaher during the second quarter valued at $25,000. nVerses Capital LLC acquired a new stake in Danaher during the second quarter worth approximately $25,000. MFA Wealth Advisors LLC bought a new stake in Danaher in the second quarter worth approximately $51,000. Financial Connections Group Inc. acquired a new position in Danaher in the second quarter valued at approximately $51,000. Finally, Western Pacific Wealth Management LP bought a new position in shares of Danaher during the 1st quarter worth approximately $55,000. 79.05% of the stock is owned by institutional investors.
Insider Activity
In other news, SVP Georgeann Couchara sold 952 shares of the company’s stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the sale, the senior vice president now directly owns 4,212 shares in the company, valued at $1,130,374.44. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 11.10% of the stock is owned by company insiders.
Wall Street Analysts Forecast Growth
View Our Latest Stock Analysis on DHR
Danaher Trading Down 0.9 %
NYSE DHR opened at $243.25 on Tuesday. The business’s fifty day moving average is $264.89 and its 200-day moving average is $260.84. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The stock has a market capitalization of $175.69 billion, a price-to-earnings ratio of 46.42, a PEG ratio of 4.51 and a beta of 0.85. Danaher Co. has a one year low of $193.75 and a one year high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The company’s revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the company earned $2.02 earnings per share. Equities research analysts predict that Danaher Co. will post 7.51 EPS for the current year.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Stockholders of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. The ex-dividend date of this dividend was Friday, September 27th. Danaher’s payout ratio is currently 20.61%.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Want to Profit on the Downtrend? Downtrends, Explained.
- 2 Chip Stocks Benefitting from OpenAI’s Chip Strategy Expansion
- Most active stocks: Dollar volume vs share volume
- Monday.com’s Manic Price Pullback Is a Signal to Buy
- Ride Out The Recession With These Dividend Kings
- 3 “Made in America” Stocks to Benefit From the Trump Presidency
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.